Cargando…

Editorial: Metabolic associated fatty liver disease: clinical perspectives from pathogenesis to diagnosis and treatment

Detalles Bibliográficos
Autores principales:	Huang, Zhe, Ye, Dewei, Loomes, Kerry, Cheng, Kenneth Kingyip, Hui, Hannah Xiaoyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352314/ https://www.ncbi.nlm.nih.gov/pubmed/37469990 http://dx.doi.org/10.3389/fendo.2023.1206642

Ejemplares similares

Editorial: Interaction of endocrine disorders and metabolic associated fatty liver disease: the genetic and epigenetic basis
por: Pan, Qin, et al.
Publicado: (2023)

IRX3 plays an important role in the pathogenesis of metabolic-associated fatty liver disease by regulating hepatic lipid metabolism
por: Ma, Yongqiang, et al.
Publicado: (2022)

Editorial: Obesity, Smoking, and Fatty Liver Disease
por: Sinha-Hikim, Amiya P., et al.
Publicado: (2018)

Editorial: Emerging Roles of the Gut Microbiota in the Pathogenesis of Metabolic Disorders
por: Moreno-Indias, Isabel, et al.
Publicado: (2021)

Editorial: Current perspectives in the diagnosis of parathyroid disease
por: Hiramitsu, Takahisa, et al.
Publicado: (2023)

Editorial: Recent Advances in Pheochromocytoma and Paraganglioma: Molecular Pathogenesis, Clinical Impacts, and Therapeutic Perspective
por: Islam, Farhadul, et al.
Publicado: (2021)

Impact of Porphyromonas gingivalis-odontogenic infection on the pathogenesis of non-alcoholic fatty liver disease
por: Liu, Linbo, et al.
Publicado: (2023)

Understanding gut-liver axis nitrogen metabolism in Fatty Liver Disease
por: Delgado, Teresa C., et al.
Publicado: (2022)

Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications
por: Yepmo, Melissa, et al.
Publicado: (2022)

Editorial: Double-Edged Swords: Genetic Factors That Influence the Pathogenesis of Both Metabolic Disease and Cancer
por: Kung, Che-Pei, et al.
Publicado: (2019)

Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease
por: Wu, Tingfeng, et al.
Publicado: (2021)

The role of TRIM family in metabolic associated fatty liver disease
por: Zhang, Jingyue, et al.
Publicado: (2023)

A Bidirectional Relationship Between Hyperuricemia and Metabolic Dysfunction-Associated Fatty Liver Disease
por: Yang, Chengzhang, et al.
Publicado: (2022)

Cardiometabolic index: A new predictor for metabolic associated fatty liver disease in Chinese adults
por: Duan, Shaojie, et al.
Publicado: (2022)

High-Sensitive CRP Correlates With the Severity of Liver Steatosis and Fibrosis in Obese Patients With Metabolic Dysfunction Associated Fatty Liver Disease
por: Zhu, Cuiling, et al.
Publicado: (2022)

Editorial: The roles and mechanisms of hepatokines, adipokines and myokines in the development of non-alcoholic fatty liver disease (NAFLD)
por: Lu, Yan
Publicado: (2022)

Editorial: The role of exosomes and organokines in metabolic and endocrine disease
por: Wang, Qi-Yu, et al.
Publicado: (2023)

Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
por: Lei, Fang, et al.
Publicado: (2023)

Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease
por: Wang, Hongyan, et al.
Publicado: (2023)

Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease
por: Lyu, Jingting, et al.
Publicado: (2022)

Pathogenesis Based Diagnosis and Treatment of Endometriosis
por: Koninckx, Philippe R., et al.
Publicado: (2021)

Association of Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Stiffness With Bone Mineral Density in American Adults
por: Li, Hejun, et al.
Publicado: (2022)

Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
por: Lee, Chi-Ho, et al.
Publicado: (2023)

Editorial: Advances and perspectives in neuroplacentology
por: Vacher, Claire-Marie, et al.
Publicado: (2023)

Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches
por: Giannoukakis, Nick, et al.
Publicado: (2023)

Editorial: The link between metabolic syndrome and chronic kidney disease: Focus on diagnosis and therapeutics
por: Hou, Ningning, et al.
Publicado: (2022)

Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
por: Wen, Wen, et al.
Publicado: (2022)

Alternative RNA Splicing in the Pathogenesis of Liver Disease
por: Webster, Nicholas J. G.
Publicado: (2017)

Editorial: The clinical application and progress of precise diagnosis and treatment of thyroid tumors
por: Tang, Jiajia, et al.
Publicado: (2023)

Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
por: Wang, Mina, et al.
Publicado: (2020)

Metabolic dysfunction-associated fatty liver disease is an early predictor for testosterone deficiency in aging men without metabolic syndrome
por: Liu, Chia-Chu, et al.
Publicado: (2023)

Clinical features and metabolic complications for non-alcoholic fatty liver disease (NAFLD) in youth with obesity
por: Barbieri, Emiliano, et al.
Publicado: (2023)

Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
por: Lee, Sejeong, et al.
Publicado: (2023)

The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease
por: Hu, Yingying, et al.
Publicado: (2023)

The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer
por: Wei, Suosu, et al.
Publicado: (2023)

Prevalence and associated factors of metabolic-associated fatty liver disease in overweight Finnish children and adolescents
por: Riekki, Hanna, et al.
Publicado: (2023)

Using hyperhomocysteinemia and body composition to predict the risk of non-alcoholic fatty liver disease in healthcare workers
por: Hao, Xiaoyan, et al.
Publicado: (2023)

Effects of scoparone on non-alcoholic fatty liver disease revealed by RNA sequencing
por: Huang, Xiaoyan, et al.
Publicado: (2022)

Editorial: Study of pancreatic islets based on human models to understand pathogenesis of diabetes
por: Imai, Yumi, et al.
Publicado: (2023)

J-Shaped Relationship Between Serum Prolactin and Metabolic-Associated Fatty Liver Disease in Female Patients With Type 2 Diabetes
por: Zhu, Cuiling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gsnl8jpifennmjcgrp2gj71pb7